Citation:Senra JC, Roque M, Talim MCT, Reis FM, Tavares RLC 2018
From Cancer Guidelines Wiki
Citation
Senra JC, Roque M, Talim MCT, Reis FM, Tavares RLC. Gonadotropin-releasing hormone agonists for ovarian protection during cancer chemotherapy: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2018 Jan;51(1):77-86 Available from: http://www.ncbi.nlm.nih.gov/pubmed/29055060.
Critical appraisals
| Critical appraisal link | Clinical question | Assigned to | Status |
|---|---|---|---|
| Senra JC, Roque M, Talim MCT, Reis FM, Tavares RLC 2018 | Ovarian suppression during chemotherapy | Dr Wanyuan Cui MBBS BMEDSCI FRACP | completed |
Compare quality appraisals for each clinical question
- [[Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?|Invalid title «<span class="smw-format list-format "><span class="smw-row"><span class="smw-field"><span class="smw-value">Clinical question:In female cancer patients does ovarian suppression with gonadotropin releasing hormone (GnRH) analogues or antagonists during chemotherapy reduce the risk of primary ovarian insufficiency?</span></span></span></span>»]] (compare critical appraisals)